Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goreisan for pain relief in glossodynia
jRCTs071200017Completed
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of oreongsan in glossodynia (BMS). Primary endpoint: Self-filled pain scale (VAS). Started Oct 2020; status: completed.
02
Drugs
oreongsan
03
Conditions
glossodynia (BMS)
Beyond the preview
Go deeper on jRCTs071200017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071200017.